Godrej Agrovet FY26 PAT ₹445 Cr; Recommends 110% Dividend

INDUSTRIAL-GOODSSERVICES
Whalesbook Corporate News Logo
AuthorAkshat Lakshkar|Published at:
Godrej Agrovet FY26 PAT ₹445 Cr; Recommends 110% Dividend
Overview

Godrej Agrovet announced its audited FY26 results, reporting ₹9,356 crore in consolidated revenue and ₹445 crore in profit after tax. The company's board has recommended a final dividend of 110% (₹11 per share). The results show a divergence, with standalone profit ₹526 crore surpassing consolidated PAT, indicating segment-specific performance nuances. The proposed dividend is a significant positive for shareholders.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

Godrej Agrovet FY26: Consolidated PAT ₹445 Cr; Standalone PAT ₹526 Cr

Consolidated revenue stood at ₹9,356.15 crore, with profit after tax at ₹445.18 crore.
Reader Takeaway: Profit driven by strong standalone performance; revenue growth remains a key focus area.

What just happened (today’s filing)

Godrej Agrovet Limited has announced its audited financial results for the fiscal year ended March 31, 2026.

The company reported consolidated revenue from operations at ₹9,356.15 crore and a consolidated profit after tax (PAT) of ₹445.18 crore for FY26.

On a standalone basis, revenue was ₹7,722.47 crore, with a higher PAT of ₹526.26 crore.

The Board has recommended a final dividend of 110%, translating to ₹11 per equity share, subject to shareholder approval.

Additionally, 30,973 equity shares were allotted under the Employees Stock Grant Scheme 2018 (ESGS 2018), slightly increasing the paid-up equity share capital.

Why this matters

The recommended dividend offers a direct return to shareholders, making the stock more attractive.

The divergence between standalone and consolidated PAT suggests that certain business segments may be performing better than others, requiring deeper analysis.

The backstory (grounded)

In the preceding fiscal year (FY25), the company's animal feed segment experienced margin pressures due to rising raw material costs, impacting overall profitability.

Godrej Agrovet has been strategically focusing on expanding its oil palm plantations, a long-term growth driver for the agribusiness.

What changes now

Shareholders can anticipate a dividend payout if approved at the upcoming Annual General Meeting (AGM).

There will be a marginal increase in the total equity share capital due to the ESGS 2018 allotment.

Management commentary at the AGM or subsequent investor calls will be crucial for understanding segment-wise performance drivers.

Risks to watch

No significant recent regulatory actions, penalties, or major governance issues for Godrej Agrovet were identified in public domain searches.

Peer comparison

Key listed peers include PI Industries Ltd., UPL Ltd. in the crop protection space, and Venky's (India) Ltd. in the animal health and poultry sector.

While PI Industries and UPL often showcase robust growth driven by exports, Venky's performance can be more cyclical, tied to market conditions.

Context metrics (time-bound)

  • The company is a diversified agribusiness player with core interests in animal feed, crop protection, dairy, and oil palm.

What to track next

  • Shareholder approval for the 110% final dividend at the 35th AGM on August 5, 2026.
  • The actual payment of the recommended dividend, expected by August 10, 2026.
  • Management's outlook on revenue growth drivers and margin performance for FY27.
  • Performance trends across key segments like animal feed and crop protection.
  • Any further updates on the oil palm expansion strategy.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.